Informative reports about Rapid scan, treatment, and outcomes data—to help hospitals make informed decisions.
Introducing RapidAI Insights
Benefits
The latest in artificial intelligence for fast, automated identification of suspected intracranial hemorrhage.
Automatically generates measurements to indicate early ischemic change on NCCT scans.
Fast Identification of Suspected LVOs and regions of asymmetry in blood vessel density.
Fast, automated assessment of patients who are likely to benefit from endovascular thrombectomy.
Automatically identifies brain areas with low ADC values and delayed contrast arrival.
Get notifications for new cases and access Rapid results using Google Chrome or Microsoft Edge on any desktop or laptop — saving you and your patients precious time.
Anytime, anywhere access to Rapid results plus the ability to communicate about patient care.
"Patients often arrive at the hospital several hours after stroke symptom onset. Rapid allows us to see the status of the brain upon arrival and to quickly identify patients who are eligible for clot removal, even as late as 24 hours after stroke onset. This increases the chances for recovery for our patients, reduces disability and saves lives."
“This novel model for delivering acute stroke treatment is advancing stroke care in Houston and has the potential for broad impact across the nation. iSchemaView’s Rapid is an important tool to speed our ability to properly triage patients.”
“...This is an extremely valuable tool for our stroke team members and a huge asset for our patients.”
“As a leader, you are always looking for ways to make work smarter, not harder for your staff. The communication challenge was continuously identified as THE barrier to making the intervention team more efficient. Being able to provide them with the Rapid app and watch them ‘fly’ has been very rewarding. In the end it is all about safe, fast and efficient work flows that provide our patients the best opportunity to recover. The app has been a great tool to make that happen.”
